Evercon 0.5mg Tablet

Evercon 0.5 mg tablet is an antineoplastic drug belonging to the class of mTOR inhibitors, containing the active ingredient everolimus. It is used to treat advanced breast cancer, renal cell carcinoma, pancreatic neuroendocrine tumours, and subependymal giant cell astrocytoma (tumours found in the ventricles of the brain). Good oral hygiene and regular dental check-ups are important during treatment, as this medicine can cause mouth sores or ulcers. It is often combined with cyclophosphamide, an alkylating agent, to treat subependymal giant cell astrocytoma. Before taking this medicine, be aware that your risk of bacterial or viral infection increases with this treatment. If you have been infected with Hepatitis B, Evercon 0.5 mg tablet increases the chances of reinfection. Inform your healthcare provider if you experience fever, chills, cough, yellowing of skin, joint pain or swelling during treatment. Limit your exposure to sunlight and UV light by wearing protective clothing and applying sunscreen frequently, as this medicine may increase the risk of developing cancers. Avoid grapefruit juice or grapefruit while taking this medicine. Evercon 0.5 mg tablets are not recommended for adolescents and children under 18 years of age. Contact your doctor immediately if you experience shortness of breath, chest pain or worsening cough. During treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes and kidney parameters to prevent serious complications. This medicine has the potential to cause kidney problems. Report to your doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels or hypertension before starting this treatment. Avoid live vaccines and close contact with those who have received live vaccines.

Advanced breast cancer Advanced renal cell carcinoma Advanced pancreatic neuroendocrine tumours Treatment of subependymal giant cell astrocytoma

Evercon 0.5 mg tablet works by inhibiting the activity of a protein called mammalian target of rapamycin (mTOR), which regulates cell growth. This drug can slow the growth of abnormal cancer cells by blocking the mTOR protein. It mainly helps to reduce the size of tumours and improve outcomes in patients.

Your doctor will decide the dose and duration of Evercon 0.5 mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet at the same time every day, with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water. If you forgot to take the tablet, simply take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious Difficulty breathing, or swallowing Swelling of face, lips, tongue, throat Severe itching, red rash, raised bumps Common Infection (chills, increased temperature) Coughing Wheezing Excessive thirst High urine output or severely decreased urine output Tiredness Bleeding Increased appetite with weight loss

Evercon 0.5 mg tablets have the tendency to cause harm to unborn foetus. Inform your healthcare provider before starting this treatment if you are pregnant, or have a partner who can become pregnant. Your health care provider will conduct a pregnancy test before you start treatment with this drug. Discuss effective birth control methods with your healthcare provider and use them during treatment and for 8 weeks after your last dose. Occurrence of mouth ulcers or sores are pretty common during this treatment, so your healthcare provider will prescribe a mouthwash. Use the mouthwash as recommended which helps prevent and manage the symptoms.